i would not be surprised if they just offer scrip.No point in offering cash IMO. Companies with the market cap of NKP can't really afford to use up their cash on an acquisition.
RGT Is the ASX OK? Argent Biopharma plummets as it leaves the bourse one day after Marley spoon; low liquidity blamed